Biogen Inc.

A class action has been filed on behalf of Biogen Inc. (the “Company”) (NASDAQ: BIIB) investors accusing certain officers and directors of the Company of violating the federal securities laws.  The lawsuit seeks recovery of investor losses.  If you purchased the Company’s securities and held them through November 6, 2020, you may be eligible to participate in the lawsuit.

Any investor with a loss may participate in the lawsuit and should contact Phillip Kim, Esq. of The Rosen Law Firm PA  at [email protected] or 212-686-1060 or click “Join This Class Action.”

Class Period:July 22, 2020 through November 6, 2020
If you purchased Biogen securities during Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, certain officers and directors of the Company violated the federal securities laws.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top